Christopher F. Wyatt - 16 Feb 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: SVP & Controller
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 16 Feb 2024
Transactions value $: -$609,695
Form type: 4
Filing time: 21 Feb 2024, 19:36:17 UTC
Previous filing: 07 Feb 2024
Next filing: 29 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+5.02K	+13.43%	$0.00	42.4K	16 Feb 2024	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$610K	-1.98K	-4.66%	$308.55	40.4K	16 Feb 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 3, 2021, the reporting person was granted 2,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Content

On February 3, 2021, the reporting person was granted 2,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.